activity - Thu, 08/03/2018 - 19:40

Microelectromechanical applied to regenerative medicine and drug discovery

Scaleable colloidal nanothrusters for extremely precise spacecraft attitude control – originating in ESA’s microelectromechanical systems (MEMS) for space programme – are being applied to the production of electrospun nanofibre scaffolds for regenerative medicine and drug discovery. Electrospun nanofibres are fabricated into non-woven scaffolds that support the 3D growth of cells. This technique is being used in regenerative medicine and drug discovery. The technology of electrospun nanofibres has further applications from rechargeable batteries to medical devices. The Electrospinning Company has been assisted by ESA’s UK Technology Transfer Broker and is currently being incubated at ESA’s Harwell Business Incubation Centre.

Organization:
ESA
Directorate:
TEC
Keywords:
Health
Innovation
Medical
Regions:
Global
Type:
Technology Transfer